Luis Matamala
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
-
- Carcinogens and Genotoxicity Assessment
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 8
-
- Melanoma and MAPK Pathways 4
- Co-authors
- Georgina V. Long (9 shared papers)Helen Gogas (9 shared papers)Dirk Schadendorf (9 shared papers)Stéphane Dalle (9 shared papers)Piotr Rutkowski (9 shared papers)J. Menezes (9 shared papers)Evan J. Lipson (9 shared papers)Ana Arance (9 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (1 paper)Annals of Oncology (1 paper)Oncotarget (1 paper)Color Research & Application (1 paper)
- Partner nations
- ChileUnited StatesBrazil
In The Last Decade
Luis Matamala
13 papers receiving 412 citations
Peers
Comparison fields: 5 of 52
- Oncology 241
- Cancer Research 86
- Immunology 118
- Health, Toxicology and Mutagenesis 53
- Chemical Health and Safety 1
Countries citing papers authored by Luis Matamala
This map shows the geographic impact of Luis Matamala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Matamala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Matamala more than expected).
Fields of papers citing papers by Luis Matamala
This network shows the impact of papers produced by Luis Matamala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Matamala. The network helps show where Luis Matamala may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Matamala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 120 | |
| 2 | 2023 | 79 | |
| 3 | 1983 | 74 | |
| 4 | 2022 | 33 | |
| 5 | 2024 | 30 | |
| 6 | 2017 | 29 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2025 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2021 | 4 | |
| 13 | 1990 | 3 | |
| 14 | 2018 | 0 |
About Luis Matamala
Luis Matamala is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Genetics, having authored 14 papers that have together received 421 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (8 papers), Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (2 papers), Gastric Cancer Management and Outcomes (2 papers), Metastasis and carcinoma case studies (1 paper), Genomic variations and chromosomal abnormalities (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (241 citations), Cancer Research (86 citations), Immunology (118 citations), Health, Toxicology and Mutagenesis (53 citations) and Chemical Health and Safety (1 citation). Luis Matamala has collaborated with scholars based in Chile, United States and Brazil. Frequent co-authors include Georgina V. Long, Helen Gogas, Dirk Schadendorf, Stéphane Dalle, Piotr Rutkowski, J. Menezes, Evan J. Lipson, Ana Arance, F. Stephen Hodi and Shigeji Kitamori. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Oncotarget and Color Research & Application.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.